Abstract
Background
Sex hormones are important for breast cancer but it is unclear whether dietary patterns influence hormone concentrations.
Methods
Dietary pattern adherence scores for the alternate Mediterranean diet (aMED), Dietary Approaches to Stop Hypertension (DASH) and Alternative Healthy Eating Index (AHEI) were calculated from semiquantitative food frequency questionnaires administered in 1995 and 1999. Premenopausal plasma concentrations of sex hormones were measured in samples collected in 1996–1999. We used generalized linear models to calculate geometric mean hormone concentrations across quartiles of dietary pattern scores among 1,990 women in the Nurses’ Health Study II.
Results
We did not observe significant associations between sex hormone concentrations and the DASH pattern, and only one suggestive association between follicular estrone concentrations and the aMED pattern (top vs. bottom quartile −4.4%, (95%CI −10.6%, 2.1%), p-trend=0.06). However, women in the top vs. bottom quartile of AHEI score had lower concentrations of follicular (−9.1%, 95%CI: −16.1%, −1.4%; p-trend=0.04) and luteal (−7.5%, 95%CI: −13.6%, −0.9%; p-trend=0.01) estrone, luteal free (−9.3%, 95%CI: −16.8%, −1.1%; p-trend=0.01), and total (−6.7 %, 95%CI: −14.3%, 1.5%; p-trend=0.04) estradiol, follicular estradiol (−14.2 %, 95%CI: −24.6%, −2.4%; p-trend=0.05) and androstenedione (−7.8%, 95%CI: −15.4%, 0.4%; p-trend=0.03).
Conclusion
Diet quality measured by the AHEI is inversely associated with premenopausal estrogen concentrations. Given we did not observe similar associations with the aMED or DASH patterns, our findings should be interpreted with caution.
Impact
Given the role of estrogens in breast cancer etiology, our findings add to the substantial evidence on the benefits of adhering to a healthy diet.
Keywords: Dietary patterns, sex hormones, premenopausal
Introduction
Sex hormone concentrations have been consistently associated with risk of postmenopausal breast cancer (1, 2), and evidence suggests they also are important in risk of premenopausal breast cancer (3, 4). Although alcohol consumption has been associated with premenopausal sex hormone concentrations (5–7), the potential influence of other dietary factors on premenopausal sex hormone concentrations is unclear. A meta-analysis of 10 intervention studies suggested reductions in estrogen levels with a low-fat and high-fiber dietary intervention (8), however many of the component studies suffered from serious methodological flaws, including lack of a control group and the inability to distinguish influences of the diet from the subsequent weight loss that occurred with the dietary modification (9). In several large cross-sectional studies (n=595, 393, 90), including our previous smaller study within the Nurses’ Health Study II (NHSII) (10), fiber intake was unrelated to premenopausal sex hormone concentrations (10–12). However, wheat bran supplementation reduced serum estrogen concentrations in an randomized study of 58 premenopausal women (13). While positive associations of saturated fat (11) and total fat (14) with estrogen concentrations have been observed in cross-sectional studies of premenopausal Japanese women, no associations were observed for total fat in other cross-sectional studies, including our own (10, 15).
Considering overall dietary quality instead of individual food components may be advantageous when evaluating health impacts of diet due to the potential synergistic effects of nutrients, which may be more easily detected than benefits of single nutrients in isolation (16, 17). Several healthy dietary patterns, including the Alternative Healthy Eating Index (AHEI) (18), the Dietary Approaches to Stop Hypertension (DASH) (19), and the alternate Mediterranean diet (aMED) (20) indices for diet quality have been linked with risk of cancer (21–24), cardiovascular disease (22, 23, 25), type 2 diabetes mellitus (22, 23), and mortality (23, 26, 27). Further, the AHEI, aMED and DASH dietary scores were inversely associated with estrogen receptor (ER) negative breast tumors in large prospective studies (28, 29). Additionally, inverse associations were observed between AHEI score and concentrations of several estrogens among 578 postmenopausal women, although the associations were largely accounted for by body mass index (30). To our knowledge, no studies have examined associations between overall dietary patterns and premenopausal sex hormone levels, which are complicated by the variation in sex hormone concentrations across the menstrual cycle. The NHSII provides a unique opportunity to investigate the associations between the AHEI, aMED and DASH dietary patterns and premenopausal sex hormone concentrations timed within the menstrual cycle. Understanding whether dietary patterns influence premenopausal sex hormone levels may further our understanding of associations between dietary patterns and breast cancer in prior studies.
Materials and Methods
Study Population
The NHSII is a prospective cohort established in 1989 among 116,430 female registered nurses, ages 25 to 42 years. Women in this cohort completed a baseline questionnaire and are followed biennially to update exposure information and ascertain disease diagnoses. Between 1996 and 1999, a total of 29,611 women in the NHSII (ages 32–54 years) provided blood samples. A description of the blood collection procedure has been detailed in a prior publication (31). Briefly, early follicular (3–5 day) and mid-luteal (7–9 days before expected start of next cycle) blood samples were obtained from 18,521 premenopausal women who had neither taken oral contraceptives nor been pregnant or breastfed within 6 months from blood draw. Women aliquoted and froze follicular samples 8 to 24 hours after collection. A single untimed blood sample was collected from the remaining 11,090 women. All samples were shipped overnight on ice and processed by our laboratory into plasma, red blood cell, and white blood cell components; samples have been stored in continuously monitored liquid nitrogen freezers since collection. The stability of sex hormone concentrations over time using these methods has been demonstrated (32).
Women in this cross-sectional study have served as controls in nested case-control studies of breast cancer (n=1,252)(3), ovarian cancer (n=43) (33), endometriosis (n=569), and rheumatoid arthritis (n=18) (34), or as participants in a hormone reproducibility study(n=108) (32). A total of 1,990 premenopausal women with measures of diet and sex hormone concentrations were included in this analysis. This study was approved by the Committee on the Use of Human Subjects in Research at the Brigham and Women’s Hospital, Boston, MA.
Laboratory assays
The details of laboratory assay methods used to quantify plasma concentrations of estrogens, androgens, progesterone, prolactin and SHBG have been described previously (35, 36). Luteal and follicular samples were assayed for estrone, estradiol, and estrone sulfate. Testosterone, androstenedione, and prolactin concentrations were assayed in luteal and/or follicular samples as well as untimed samples. DHEA, DHEAS and SHBG were measured in luteal and untimed samples and progesterone was measured in luteal samples. Assays were performed in different batches at different laboratories. Some batches of estrogens (n=3), testosterone (n=5), androstenedione (n=2), and progesterone (n=1) were assayed at Quest Diagnostics. Organic extraction and celite column chromatography followed by radioimmunoassay (RIA) were used to quantify estrogens and testosterone. Estrone sulfate was assessed by RIA of estrone, after extraction of estrone, enzyme hydrolysis, and column chromatography. Organic extraction and RIA was used to assay progesterone. Four batches of estrogens and testosterone were assayed at Mayo Medical Laboratories using liquid chromatography-tandem mass spectrometry. Two batches of DHEA and androstenedione and four batches of DHEAS, SHBG, and progesterone were assayed at the Royal Marsden Hospital (London, United Kingdom). Androstenedione was assayed by RIA and DHEAS, SHBG and progesterone were assayed by chemiluminescent enzyme immunoassay. One batch of progesterone (RIA) and three batches of SHBG (chemiluminescent enzyme immunoassay) were assayed at Massachusetts General Hospital (Boston, MA) and one batch of SHBG and progesterone were assayed at the Children’s Hospital Boston (Boston, MA). Prolactin was measured using microparticle enzyme immunoassay at the Massachusetts General Hospital using the AxSYM Immunoassay system. We included 10% blinded replicates in each batch to assess laboratory precision. Except for a single batch of progesterone (17%), within-batch coefficients of variation were between 2% and 15% for all analytes.
Dietary assessment
Starting in 1991, women completed a validated semiquantitative food frequency questionnaire (FFQ) every four years assessing usual intake of the most commonly eaten foods during the past year (37, 38). For this study, average aMED, AHEI, and DASH dietary pattern adherence scores were calculated from the 1995 and 1999 FFQs.
Scoring methods for dietary pattern indices have been described in detail elsewhere (18, 19, 39). Briefly, for the aMED score, women were assigned 1 point for being above the median number of servings per day for the following components; fruit, vegetables, legumes and soy, nuts, fish and seafood, whole grains and the ratio of monounsaturated to saturated fatty acids (MUFA:SFA). Women were assigned 1 point for red and processed meat below the median intake and 1 point for moderate alcohol intake (5–15 g/day)(28). The DASH score was derived by assigning 1 to 5 points based on quintile of intake in servings per day of fruit, vegetables, nuts, legumes and soy, red and processed meats, whole grains, low-fat dairy, and sodium in milligrams (40). Sweetened beverages were derived from quartiles of usual intake due to less variability in this measure. Scoring was inverse for red and processed meat, sugar-sweetened beverages, and sodium, with more points for less consumption. The AHEI score was modified from the Healthy Eating Index developed by the United States Department of Agriculture, and is based on consumption of 11 components; fruits, vegetables, red and processed meat, trans fat, polyunsaturated fat, long-chain (n−3) fats, whole grains, nuts and legumes, sugar-sweetened beverages and fruit juice, moderate alcohol consumption, and sodium (22). Given the association we observed between alcohol and premenopausal sex hormone concentrations (5), we omitted the alcohol component of the AHEI score for this analysis. For the AHEI score, points were assigned on a scale from 0 to 10, with 10 indicating greater adherence to the recommended levels of serving per day; intermediate scores were categorized proportionately. Total scores consisted of the sum of points across all dietary components, with a higher score indicating a higher adherence, ranging from 0 to 8 for aMED, 8 to 39 for the DASH, and 2.5 to 87.5 for the AHEI; dietary pattern scores were categorized into quartiles for analyses.
The correlations between the different dietary patterns were moderate to strong, with Spearman correlation coefficients of 0.61 between AHEI and DASH, 0.63 between AHEI and aMED, and 0.80 between DASH and aMED.
Statistical analyses
Given the normal fluctuation of sex hormone levels throughout the menstrual cycle, we examined estrogen models separately for the follicular and luteal phases and progesterone in the luteal phase, and tested for statistical interaction by menstrual cycle phase using the Wald test. Additionally, we created a score for total estrogen exposure by ranking women within distributions of estrone, estradiol and free estradiol (the estrogens available for the largest population), and summing ranks across the estrogens. As the concentrations of testosterone, free testosterone, androstenedione, and prolactin did not vary substantially by menstrual phase and the average concentration more accurately represents long-term levels (32, 41), we used the average of the follicular and luteal blood sample values, when available for these hormones. We excluded 0 (estrone sulfate) to 13 (prolactin) extreme values detected with the generalized extreme Studentized deviate (ESD) many-outlier detection approach (42). We observed batch-to-batch variation among quality control samples, and adjusted for batch according to methods described by Rosner and colleagues (43) as we have used previously(5, 44).
We assessed potential nonlinearity of continuous predictors in our model non-parametrically with stepwise restricted cubic splines (45–47). Tests for non-linearity used the likelihood ratio test to compare models with only the linear term to the model with the linear and the cubic spline terms. We used generalized linear models to estimate geometric mean hormone concentrations across quartiles of dietary pattern scores standardized to the marginal distribution of the covariates. We estimated the percentage difference and 95% confidence intervals (CI) comparing the top and bottom quartiles of dietary pattern score. We modeled each dietary pattern continuously using the median of each quartile and examined linear trends using the Wald test.
Multivariate models were adjusted for age at blood collection, date of blood collection, time of day of blood collection, fasting status, race, smoking status and duration, energy intake, alcohol consumption, physical activity in MET-hrs/wk, parity and age at first birth, age at menarche, duration of oral contraceptive use and BMI at blood draw. Covariates were chosen based on prior knowledge of factors associated with sex hormone levels and dietary intake. We additionally included variables for blood draw timing and fasting status in the model to reduce extraneous variation. Models that included luteal or average of timed samples also were adjusted for the difference between luteal blood draw date and date of next menstrual period.
We assessed whether associations differed by BMI (<25 vs. >=25 kg/m2) and age (<45 vs. >=45 years), using stratified models and we calculated p-values for interaction terms between BMI, age and a continuous dietary pattern score weighted by the median of each quartile using the Wald test. We examined multivariate models with and without BMI to assess the influence of BMI on sex hormone concentrations. We conducted a priori sensitivity analyses among ovulatory women with timed samples (defined by luteal progesterone>=400 ng/dL). All statistical tests were two-sided and considered statistically significant at p<0.05; statistical analyses were conducted using SAS software, version 9.2 (SAS Institute, Inc. Cary, NC).
Results
Women in the highest vs. lowest quartiles of the aMED, DASH, and AHEI dietary patterns were slightly older, leaner, much more likely to be physically active, less likely to be parous and to be current smokers, had a slightly older age at first birth, and were more likely to have history of benign breast disease, family history of breast cancer, and report regular menstrual cycles (Table 1). Of note, women in the highest vs. lowest quartiles of the aMED and DASH dietary patterns consumed more carbohydrates, protein, total fat and had higher energy intake overall, while women in the highest vs. lowest quartile of the AHEI pattern consumed less of these macronutrients and had lower energy intake.
Table 1.
Characteristics at blood draw of 1,990 premenopausal women in the NHSII by dietary pattern score
| Dietary Pattern | ||||||
|---|---|---|---|---|---|---|
| aMED Score | DASH Score | AHEI (no alc) | ||||
| Q1 (n=565) |
Q4 (n=481) |
Q1 (n=477) |
Q4 (n=494) |
Q1 (n=496) |
Q4 (n=497) |
|
| aMED score (mean, sd) | 2.2 (0.8) | 6.7 (0.7) | 2.5 (1.2) | 6.2 (1.1) | 3.0 (1.4) | 5.8 (1.4) |
| DASH score (mean, sd) | 19.7 (3.3) | 29.2 (3.1) | 18.0 (2.0) | 30.4 (2.0) | 20.7 (3.7) | 28.2 (3.8) |
| AHEI score (mean, sd) | 40.1 (7.0) | 55.6 (9.1) | 39.7 (6.9) | 55.8 (8.9) | 35.5 (3.8) | 60.2 (5.7) |
| Age in years (mean, sd) | 42.2 (4.1) | 43.2 (3.9) | 42.1 (4.0) | 43.5 (3.9) | 41.7 (4.1) | 43.6 (3.9) |
| Body mass index, kg/m2 (mean, sd) | 26.3 (6.8) | 25.4 (6.5) | 26.6 (7.1) | 25.4 (6.6) | 26.3 (6.8) | 25.8 (7.0) |
| Body mass index at age 18, kg/m2 (mean, sd) | 21.0 (3.1) | 21.2 (3.2) | 21.0 (3.1) | 21.2 (3.0) | 20.8 (2.8) | 21.5 (3.3) |
| Height in inches (mean, sd) | 64.6 (2.6) | 65.2 (2.6) | 64.8 (2.6) | 65.3 (2.6) | 64.8 (2.6) | 65.0 (2.5) |
| Physical Activity in MET-hrs/week (mean, sd) | 14.2 (15.4) | 23.6 (20.5) | 14.5 (16.5) | 23.7 (20.7) | 12.6 (12.8) | 22.5 (20.6) |
| Energy intake, g/day (mean, sd) | 1,622 (441) | 2,109 (474) | 1,635 (472) | 2,069 (467) | 1,962 (502) | 1,784 (493) |
| Carbohydrates, g/day(mean, sd) | 202 (65.8) | 288 (70.1) | 200 (69.2) | 290 (65.9) | 252 (72.7) | 242 (76.4) |
| Protein, g/day (mean, sd) | 73.7 (19.8) | 93.9 (24.6) | 72.5 (20.2) | 93.5 (25.1) | 85.2 (22.6) | 82.6 (25.0) |
| Total fat, g/day (mean, sd) | 58.4 (19.0) | 65.8 (20.8) | 60.6 (20.4) | 62.1 (20.7) | 69.1 (21.0) | 55.6 (20.2) |
| Animal fat, g/day (mean, sd) | 34.5 (12.3) | 30.5 (13.5) | 35.1 (12.7) | 29.1 (12.7) | 40.1 (12.5) | 25.0 (11.0) |
| Vegetable fat, g/day (mean, sd) | 23.9 (9.6) | 35.3 (12.3) | 25.5 (10.3) | 33.1 (13.0) | 29.0 (11.4) | 30.6 (13.6) |
| Trans fat,g/day (mean, sd) | 2.9 (1.3) | 2.6 (1.4) | 3.2 (1.5) | 2.4 (1.2) | 3.7 (1.5) | 2.0 (1.0) |
| Fiber, g/day (mean, sd) | 14.0 (4.3) | 28.0 (7.8) | 13.7 (4.1) | 28.4 (8.1) | 16.7 (5.6) | 25.3 (9.5) |
| Alcohol consumption in g/day (mean, sd) | 2.6 (5.9) | 5.8 (7.0) | 3.2 (5.8) | 4.5 (6.6) | 2.9 (6.1) | 4.6 (6.5) |
| Parous (%) | 85.0% | 73.4% | 82.2% | 73.5% | 88.1% | 70.0% |
| Paritya (mean, sd) | 2.1 (1.2) | 1.7 (1.3) | 2.0 (1.3) | 1.7 (1.3) | 2.2 (1.3) | 1.5 (1.2) |
| Age at first birtha (mean, sd) | 26.0 (4.3) | 27.1 (4.9) | 26.1 (4.3) | 27.4 (4.9) | 26.2 (4.1) | 27.4 (4.8) |
| Past oral contraceptive use (%) | 86.4% | 84.6% | 88.1% | 82.8% | 86.5% | 82.9% |
| Past breast feeding history (%) | 67.8% | 64.7% | 63.7% | 65.4% | 70.8% | 60.0% |
| Current smoker (%) | 9.4% | 6.0% | 12.8% | 5.1% | 10.1% | 5.2% |
| Family history of breast cancer (%) | 7.8% | 11.2% | 9.4% | 9.7% | 7.3% | 10.9% |
| Benign breast disease history (%) | 42.5% | 47.8% | 43.0% | 49.4% | 38.5% | 49.3% |
| Caucasian (%) | 95.8% | 93.6% | 95.6% | 93.3% | 94.4% | 93.0% |
| Age at menarche between 12–13 years (%) | 59.1% | 63.4% | 58.7% | 61.1% | 61.5% | 58.4% |
| Usual menstrual cycle pattern regular (%) | 90.6% | 93.5% | 89.1% | 93.7% | 89.2% | 95.4% |
Among parous women
The DASH dietary pattern was not significantly associated with any of the sex hormone concentrations examined (Table 2). We observed a suggestive inverse trend in concentrations of follicular estrone with improved aMED diet adherence (p-trend=0.06), but no other significant associations were observed for the other sex hormones and the aMED dietary pattern (Table 3). However, AHEI diet score was inversely associated with several estrogen concentrations (Table 4). Compared to women in the lowest quartile, those in the highest quartile of AHEI quality score had lower concentrations of follicular estrone (−9.1%, 95%CI: −16.1%, −1.4%; p-trend=0.04), luteal estrone (−7.5%, 95%CI: −13.6%, −0.9%; p-trend=0.01), follicular estradiol (−14.2%, 95%CI: −24.6%, −2.4%; p-trend=0.05), and luteal estradiol (−6.7%, 95%CI: −14.3%, 1.5%; p-trend=0.04) concentrations. AHEI was inversely associated with luteal free estradiol (−9.3%, 95%CI: −16.8%, −1.1%; p-trend=0.01), and suggestively with follicular free estradiol (−9.2%, 95%CI: −18.2%, 0.8%; p-trend=0.10). AHEI score was inversely associated with the total estrogen score (−5.6%, 95% CI: −11.2%, 0.4%; p-trend=0.03); we did not observe any evidence of interaction by menstrual cycle phase for the associations of AHEI score and estradiol (p-value=0.79), free estradiol (p-value=0.76), estrone (p-value=0.48) or estrone sulfate (p-value=0.58). AHEI diet score was also inversely associated with androstenedione concentrations (top vs. bottom quartile −7.8%, (95%CI: −15.4%, 0.4%), p-trend=0.03). We did not observe any other significant associations between the AHEI dietary score and premenopausal concentrations of estrone sulfate, progesterone, prolactin, SHBG and other androgens including DHEA, DHEAS, testosterone, or free testosterone. Results for the observed associations with dietary patterns did not differ in analyses stratified by age or BMI, or in models restricted to blood samples collected during ovulatory cycles (data not shown). Further, results were generally similar in multivariate models unadjusted for BMI, although the associations between AHEI diet score and follicular (p-trend=0.16) and luteal (p-trend=0.06) estradiol were no longer statistically significant in models unadjusted for BMI. We observed statistically non-linear associations between aMED and free testosterone (p-value=0.04), and DASH and follicular estrone sulfate (p-value =0.03). Thus, we did not estimate a p-value for trend for these associations.
Table 2.
Adjusted geometric mean concentration of plasma hormones by DASH dietary pattern score quartiles among up to 1,990 premenopausal women in the Nurses’ Health Study II
| DASH score | p-value trend, median of Qs |
Percent differenceb and 95% CI | |||||
|---|---|---|---|---|---|---|---|
| Hormone | N | Q1 | Q2 | Q3 | Q4 | ||
| Range | (11.5–20.5) | (21.0–24.0) | (24.5–27.5) | (28.0–36.5) | |||
| Follicular Estradiol (pg/mL) | 1,397 | 69.9 | 67.2 | 62.6 | 64.5 | 0.13 | −7.7% (−19.0%, 5.3%) |
| Luteal Estradiol (pg/mL) | 1,524 | 152 | 152 | 154 | 153 | 0.84 | 0.5% (−7.6%, 9.2%) |
| Follicular Free Estradiol | 1,361 | 0.73 | 0.73 | 0.67 | 0.73 | 0.52 | −0.2% (−9.7%, 10.4%) |
| Luteal Free Estradiol | 1,508 | 1.88 | 1.90 | 1.86 | 1.85 | 0.65 | −1.6% (−10.2%, 7.8%) |
| Follicular Estrone (pg/mL) | 1,417 | 48.3 | 47.5 | 45.0 | 45.9 | 0.11 | −4.9% (−11.9%, 2.6%) |
| Luteal Estrone (pg/mL) | 1,571 | 90.8 | 90.5 | 91.6 | 89.2 | 0.74 | −1.7% (−8.7%, 5.7%) |
| Follicular estrone sulfate (pg/mL) | 444 | 761 | 881 | 833 | 779 | * | 2.3% (−19.9%, 30.6%) |
| Luteal estrone sulfate (pg/mL) | 449 | 1,608 | 1,729 | 1,454 | 1,361 | 0.14 | −15.4% (−37.3%, 14.2%) |
| Luteal Progesterone (ng/dL) | 1,587 | 1,180 | 1,176 | 1,241 | 1,241 | 0.18 | 5.2% (−4.1%, 15.4%) |
| DHEA (ng/dL)c | 386 | 774 | 863 | 757 | 707 | 0.08 | −8.7% (−19.9%, 4.2%) |
| DHEAS (µg/dL)c | 1,083 | 124 | 125 | 124 | 126 | 0.84 | 1.6% (−8.8%, 13.1%) |
| Testosterone (ng/dL)d | 1,956 | 23.9 | 23.4 | 24.1 | 23.7 | 0.95 | −0.9%(−6.3%, 4.8%) |
| Free testosterone (ng/dL)d | 1,898 | 0.19 | 0.19 | 0.19 | 0.19 | 0.81 | 0.3% (−6.6%, 7.6%) |
| Androstenedione (ng/dL)d | 626 | 126 | 132 | 128 | 121 | 0.34 | −3.6% (−12.4%, 6.2%) |
| Prolactin (ng/dL)d | 1,300 | 22.5 | 21.1 | 20.2 | 22.4 | 0.86 | −0.3% (−10.9%, 11.6%) |
| SHBG (nmol/L)d | 1,675 | 71.8 | 69.2 | 72.3 | 70.4 | 0.93 | −1.9% (−8.3%, 5.0%) |
All geometric mean concentrations are adjusted for age at blood collection in years (continuous), BMI at blood collection in kg/m2 (<22.5, 22.5 to <25, 25 to <27.5, 27.5 to <30, 30+), total energy intake in kcal/day (continuous), smoking (never smoker, past smoker with >= 5 years since quitting, past smoker with <5 years since quitting, current smoker of <15 cigarettes per day, current smoker of 15+ cigarettes per day), alcohol use (non-drinker, <=10g/day, 10.1-20 g/day, >20 g/day) duration of past oral contraceptive use (never, <4 years, 4+ years), age at first birth/parity (nulliparous, 1–2 children and age at first birth < 25 years, 1–2 children and age at first birth > 25 years, >3 children and age at first birth < 25 years, >3 children and age at first birth > 25 years), age at menarche (<12, 12–13, >13 years), physical activity in MET-hours/week (<3, 3 to <9, 9 to <18, 18 to <27, 27+), date of blood collection (month/year, <1/97, 2/97–1/98, 2/98–1/99, >2/99), time of day of blood collection (1–8 a.m.,9 a.m. to noon, 1–4 p.m., 5 p.m. to midnight), and fasting status (<10, >10 hours). Models that included luteal or average of timed samples also were adjusted for the difference between luteal blood draw date and date of next menstrual period (3–7, 8–12,13–17, 18–21 days, unknown/untimed).
Percent difference between Q4 vs. Q1
Luteal/untimed
Average of follicular and luteal measures, or untimed
P-value for non-linearity=0.03, p-value for the overall significance of the curve=0.06
Table 3.
Adjusted geometric mean concentration of plasma hormones by aMED dietary pattern score quartiles among up to 1,990 premenopausal women in the Nurses’ Health Study II
| aMED score | p-value trend, median of Qs |
Percent differenceb and 95% CI |
|||||
|---|---|---|---|---|---|---|---|
| Hormone | N | Q1 | Q2 | Q3 | Q4 | ||
| Range | (0–3) | (3.5–4) | (4.5–5.5) | (6.0–9.0) | |||
| Follicular Estradiol (pg/mL) | 1,397 | 70.7 | 69.1 | 59.1 | 67.7 | 0.23 | −4.2% (−17.2%, 10.8%) |
| Luteal Estradiol (pg/mL) | 1,524 | 156 | 149 | 154 | 150 | 0.38 | −4.5% (−12.5%, 4.4%) |
| Follicular Free Estradiol(pg/mL) | 1,361 | 0.75 | 0.72 | 0.67 | 0.75 | 0.75 | 0.8% (−8.9%, 11.6%) |
| Luteal Free Estradiol (pg/mL) | 1,508 | 1.95 | 1.84 | 1.91 | 1.79 | 0.13 | −8.3% (−16.8%, 1.0%) |
| Follicular Estrone (pg/mL) | 1,417 | 49.3 | 47.0 | 44.6 | 47.1 | 0.06 | −4.4% (−10.6%, 2.1%) |
| Luteal Estrone (pg/mL) | 1,571 | 92.8 | 91.0 | 88.8 | 89.4 | 0.26 | −3.7% (−10.7%, 3.8%) |
| Follicular estrone sulfate (pg/mL) | 444 | 853 | 749 | 789 | 880 | 0.69 | 3.2% (−16.1%, 26.9%) |
| Luteal estrone sulfate (pg/mL) | 449 | 1,759 | 1,401 | 1,521 | 1,491 | 0.26 | −15.2% (−34.0%, 8.9%) |
| Luteal Progesterone (ng/dL) | 1,587 | 1,248 | 1,166 | 1,193 | 1,227 | 0.62 | −1.7% (−10.1%, 7.6%) |
| DHEA (ng/dL)c | 386 | 837 | 909 | 890 | 773 | 0.34 | −7.7% (−20.4%, 7.0%) |
| DHEAS (µg/dL)c | 1,083 | 123 | 126 | 129 | 124 | 0.67 | 1.1% (−8.9%, 12.3%) |
| Testosterone (ng/dL)d | 1,956 | 23.5 | 23.9 | 24.1 | 23.4 | 0.94 | −0.3% (−5.6%, 5.4%) |
| Free testosterone (ng/dL)d | 1,898 | 0.18 | 0.19 | 0.20 | 0.18 | * | −3.0% (−9.5%, 3.9%) |
| Androstenedione (ng/dL)d | 626 | 128 | 131 | 129 | 119 | 0.19 | −7.1% (−16.3%, 3.2%) |
| Prolactin (ng/dL)d | 1,300 | 22.4 | 19.6 | 21.5 | 22.7 | 0.72 | 1.5% (−9.1%, 13.4%) |
| SHBG (nmol/L)d | 1,675 | 71.5 | 70.3 | 69.3 | 72.4 | 0.89 | 1.3% (−5.5%, 8.5%) |
All geometric mean concentrations are adjusted for age at blood collection (continuous), BMI at blood collection (<22.5, 22.5 to <25, 25 to <27.5, 27.5 to <30, 30+), total kilocalories (continuous), smoking (never smoker, past smoker with >= 5 years since quitting, past smoker with <5 years since quitting, current smoker of <15 cigarettes per day, current smoker of 15+ cigarettes per day), alcohol use (non-drinker, <=10g/day, 10.1–20 g/day, >20 g/day) duration of past oral contraceptive use (never, <4 years, 4+ years), age at first birth/parity (nulliparous, 1–2 children and age at first birth < 25 years, 1–2 children and age at first birth > 25 years, >3 children and age at first birth < 25 years, >3 children and age at first birth > 25 years), age at menarche (<12, 12–13, >13 years), physical activity in MET-hours/week (<3, 3 to <9, 9 to <18, 18 to <27, 27+), date of blood collection (month/year, ≤1/97, 2/97–1/98, 2/98–1/99, ≥2/99), time of day of blood collection (1–8 a.m.,9 a.m. to noon, 1–4 p.m., 5 p.m. to midnight), and fasting status (<10, ≥10 hours). Models that included luteal or average of timed samples also were adjusted for the difference between luteal blood draw date and date of next menstrual period (3–7, 8–12,13–17, 18–21 days, unknown/untimed).
Percent difference between Q4 vs. Q1
Luteal/untimed
Average of follicular and luteal measures, or untimed
p-value for non-linearity=0.04, p-value for overall significance of the curve=0.06
Table 4.
Adjusted geometric mean concentration of plasma hormones by AHEI (not including alcohol) dietary pattern score quartiles among up to 1,990 premenopausal women in the Nurses’ Health Study II
| AHEI score | p-value trend, median of Qs |
Percent differenceb and 95% CI |
|||||
|---|---|---|---|---|---|---|---|
| Hormone | N | Q1 | Q2 | Q3 | Q4 | ||
| Range | (21.5–40.2) | (40.3–46.2) | (46.2–53.2) | (53.2–81.1) | |||
| Follicular Estradiol (pg/mL) | 1,397 | 75.3 | 60.9 | 66.5 | 64.6 | 0.05 | −14.2% (−24.6%, −2.4%) |
| Luteal Estradiol (pg/mL) | 1,524 | 156 | 159 | 150 | 146 | 0.04 | −6.7% (−14.3%, 1.5%) |
| Follicular Free Estradiol | 1,361 | 0.78 | 0.69 | 0.69 | 0.71 | 0.10 | −9.2% (−18.2%, 0.8%) |
| Luteal Free Estradiol | 1,508 | 1.92 | 1.98 | 1.89 | 1.75 | 0.01 | −9.3% (−16.8%, −1.1%) |
| Follicular Estrone (pg/mL) | 1,417 | 49.9 | 45.6 | 46.4 | 45.4 | 0.04 | −9.1%(−16.1%, −1.4%) |
| Luteal Estrone (pg/mL) | 1,571 | 91.7 | 94.5 | 91.7 | 84.9 | 0.01 | −7.5% (−13.6%, −0.9%) |
| Follicular estrone sulfate (pg/mL) | 444 | 814 | 847 | 860 | 765 | 0.43 | −6.0%(−22.2%, 13.6%) |
| Luteal estrone sulfate (pg/mL) | 449 | 1,577 | 1,690 | 1,584 | 1,468 | 0.36 | −6.9% (−24.3%, 14.5%) |
| Luteal Progesterone (ng/dL) | 1,587 | 1,189 | 1,197 | 1,233 | 1,225 | 0.45 | 3.0% (−5.9%, 12.8%) |
| DHEA (ng/dL)c | 386 | 854 | 848 | 864 | 807 | 0.46 | −5.5%(−17.8%, 8.7%) |
| DHEAS (µg/dL)c | 1,083 | 123 | 127 | 129 | 121 | 0.78 | −1.6% (−11.0%, 8.8%) |
| Testosterone (ng/dL)d | 1,956 | 23.7 | 24.5 | 24.3 | 22.8 | 0.11 | −3.7%(−8.5%, 1.3%) |
| Free testosterone (ng/dL)d | 1,898 | 0.19 | 0.20 | 0.20 | 0.18 | 0.09 | −6.0% (−12.4%, 0.9%) |
| Androstenedione (ng/dL)d | 626 | 130 | 134 | 129 | 120 | 0.03 | −7.8%(−15.4%, 0.4%) |
| Prolactin (ng/dL)d | 1,300 | 21.8 | 20.6 | 22.0 | 21.9 | 0.60 | 0.5% (−9.9%, 12.1%) |
| SHBG (nmol/L)d | 1,675 | 71.9 | 68.8 | 70.6 | 71.9 | 0.73 | −0.04% (−6.5%, 6.9%) |
All geometric mean concentrations are adjusted for age at blood collection (continuous), BMI at blood collection (<22.5, 22.5 to <25, 25 to <27.5, 27.5 to <30, 30+), total kilocalories (continuous), smoking (never smoker, past smoker with >= 5 years since quitting, past smoker with <5 years since quitting, current smoker of <15 cigarettes per day, current smoker of 15+ cigarettes per day), alcohol use (non-drinker, <=10g/day, 10.1–20 g/day, >20 g/day) duration of past oral contraceptive use (never, <4 years, 4+ years), age at first birth/parity (nulliparous, 1–2 children and age at first birth < 25 years, 1–2 children and age at first birth > 25 years, >3 children and age at first birth < 25 years, >3 children and age at first birth > 25 years), age at menarche (<12, 12–13, >13 years), physical activity in MET-hours/week (<3, 3 to <9, 9 to <18, 18 to <27, 27+), date of blood collection (month/year, <1/97, 2/97–1/98, 2/98–1/99, >2/99), time of day of blood collection (1–8 a.m.,9 a.m. to noon, 1–4 p.m., 5 p.m. to midnight), and fasting status (<10, >10 hours). Models that included luteal or average of timed samples also were adjusted for the difference between luteal blood draw date and date of next menstrual period (3–7, 8–12,13–17, 18–21 days, unknown/untimed).
Percent difference between Q4 vs. Q1
Luteal/untimed
Average of follicular and luteal measures, or untimed
To further explore which components of the AHEI dietary pattern may be driving the observed inverse associations with estrogen concentrations, we examined models of the AHEI pattern omitting individual components (Supplemental Table 1). Inverse associations of the AHEI pattern and follicular estradiol, follicular and luteal free estradiol and follicular estrone appeared to be largely driven by the sugar-sweetened beverages component. However, several components of the AHEI pattern appear to be contributing to the observed inverse associations of AHEI pattern and luteal estradiol and luteal estrone.
Discussion
In this large cross-sectional study, we observed inverse associations between overall AHEI dietary quality and estrogen concentrations among premenopausal women. However, the aMED and DASH dietary patterns were not significantly associated with plasma concentrations of sex hormones.
To our knowledge, this is the first study to examine overall dietary patterns and sex hormone concentrations among premenopausal women. Although BMI largely accounted for observed inverse associations between the AHEI dietary pattern and postmenopausal plasma estradiol and free estradiol in a prior analysis (30), this was not the case among premenopausal women. While we observed an inverse trend in concentrations of androstenedione with improving AHEI diet adherence, we did not observe any other significant associations between any of the dietary patterns and concentrations of androgens, suggesting that dietary patterns may not be strongly associated with androgen concentrations. This finding is generally consistent with the few prior studies to examine associations between specific dietary components, including fat, fiber and energy intake and premenopausal androgen concentrations (12, 48).
Although we observed several significant associations between the AHEI dietary pattern and estrogen concentrations in this study, it is not entirely clear why the AHEI pattern is associated with estrogen concentrations, while the DASH and aMED patterns, which share several common dietary components and are strongly correlated with the AHEI pattern, may not be as important. Each of these dietary patterns incorporates intakes of fruits and vegetables, whole grains, red and processed meats, and nuts and soy. Although trans fats and omega fatty acids are only included in the AHEI dietary pattern, these components were not driving the observed associations of the AHEI pattern with estrogen concentrations. However, our findings suggest that sugar-sweetened beverages may be important. While sweetened soda was positively associated with premenopausal estradiol concentrations in a prior cross-sectional study of 259 women (49), other cross-sectional studies did not observe associations between soda consumption and premenopausal sex hormones, (n=50; 498) (50, 51). Further, in a prospective study of over 18,000 women, soda consumption was positively associated with increased risk of ovulatory disorder (52), suggesting that specific components of soda may be important for reproductive function. While our results may be due in part to chance, the consistency of findings for AHEI with several estrogen concentrations warrants further investigation.
There are several biological mechanisms that may be responsible for the observed associations between AHEI and premenopausal estrogen concentrations. For example, whole grains, vegetables and other foods rich in fiber may influence estrogen metabolism (53, 54) and have been associated with a reduction in premenopausal estrogen levels in one study (13), although not in others (7, 10–12). Indeed, sources of fiber bind to estradiol (55, 56) and may reduce plasma estrogen levels by increasing fecal excretion (57, 58) as has been shown in animal studies (59). Potential biological mechanisms for associations of dietary fat and sex hormone concentrations are less clear, although dietary fat intake can increase free fatty acids which could displace estradiol from albumin, thereby increasing free estradiol concentrations (60, 61). However, SHBG concentrations may be more important determinants of free estradiol concentrations than the hypothesized displacement of estradiol, and we did not observe any associations between free estradiol levels and dietary fat in this study.
Strengths of the study include the ability to examine associations between overall dietary patterns, allowing for the synergistic effects of nutrients, and that estrogens were measured in both the follicular and luteal phases of the menstrual cycle, accounting for the variation in sex hormone concentrations across the menstrual cycle. Additionally, evaluating overall dietary quality can complement the traditional methods by providing a comprehensive representation of dietary influences that can subsequently be investigated through a single nutrient approach. To our knowledge, this is the first study to date to examine associations of diet quality scores and sex hormones concentrations among premenopausal women. We were able to account for multiple potential confounding lifestyle factors in our analysis. An additional strength of this analysis was the assessment of dietary patterns by validated FFQ. Given the cross-sectional design of this study, we are limited in our ability to attribute causality to the observed associations. Although we only had one or two timed hormone measures per participant to capture the association with habitual dietary pattern, one androgen measure is reproducible in our population of premenopausal women over 2 to 3 years [intraclass correlations (ICC), 0.58–0.94]. Although ICCs for estrogens are lower (0.38–0.69 (32), we observed several significant associations with estrogens in this study. Finally, due to the large number of associations examined as part of this study, several of which were examined without strong a priori hypotheses, we cannot rule out the possibility of observing several observations by chance.
In conclusion, we observed inverse associations between overall dietary quality measured by the AHEI and estrogen concentrations among premenopausal women, but no associations with dietary quality as assessed by aMED or DASH patterns. The observed associations with AHEI, along with the role of estrogen in breast cancer risk, and the reduced risk of other cancers (22–24), cardiovascular disease (22, 23, 25), type 2 diabetes mellitus (22, 23), and certain breast cancer subtypes (28) associated with AHEI dietary adherence, add to the substantial evidence of the health benefits of adhering to a healthy dietary pattern.
Supplementary Material
Acknowledgments
This research was supported from the NIH UM1 CA176726 (W.C. Willett) and R01 CA67262 (S.E. Hankinson). K.A. Hirko is supported by the R25 CA098566 training grant. Additional funding was provided from the NIH 5R01 CA50385-18 Sup (W.C. Willett, J.B. Barnett). We would like to thank the participants and staff of the Nurses’ Health Study II for their valuable contributions. The authors assume full responsibility for analyses and interpretation of these data.
Footnotes
The authors declare that they have no conflicts of interest.
References
- 1.Zhang X, Tworoger SS, Eliassen AH, Hankinson SE. Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat. 2013;137:883–892. doi: 10.1007/s10549-012-2391-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94:606–616. doi: 10.1093/jnci/94.8.606. [DOI] [PubMed] [Google Scholar]
- 3.Fortner RT, Eliassen AH, Spiegelman D, Willett WC, Barbieri RL, Hankinson SE. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II. Breast Cancer Res. 2013;15:R19. doi: 10.1186/bcr3394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kaaks R, Tikk K, Sookthai D, Schock H, Johnson T, Tjonneland A, et al. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort. Int J Cancer. 2014;134:1947–1957. doi: 10.1002/ijc.28528. [DOI] [PubMed] [Google Scholar]
- 5.Hirko KA, Spiegelman D, Willett WC, Hankinson SE, Eliassen AH. Alcohol consumption in relation to plasma sex hormones, prolactin, and sex hormone-binding globulin in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2014;23:2943–2953. doi: 10.1158/1055-9965.EPI-14-0982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Garcia-Closas M, Herbstman J, Schiffman M, Glass A, Dorgan JF. Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women. Int J Cancer. 2002;102:172–178. doi: 10.1002/ijc.10651. [DOI] [PubMed] [Google Scholar]
- 7.Maskarinec G, Morimoto Y, Takata Y, Murphy SP, Stanczyk FZ. Alcohol and dietary fibre intakes affect circulating sex hormones among premenopausal women. Public Health Nutr. 2006;9:875–881. doi: 10.1017/phn2005923. [DOI] [PubMed] [Google Scholar]
- 8.Wu AH, Pike MC, Stram DO. Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst. 1999;91:529–534. doi: 10.1093/jnci/91.6.529. [DOI] [PubMed] [Google Scholar]
- 9.Holmes MD, Schisterman EF, Spiegelman D, Hunter DJ, Willett WC. Re: Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst. 1999;91:1511–1512. doi: 10.1093/jnci/91.17.1511. [DOI] [PubMed] [Google Scholar]
- 10.Cui X, Rosner B, Willett WC, Hankinson SE. Dietary fat, fiber, and carbohydrate intake and endogenous hormone levels in premenopausal women. Horm Cancer. 2010;1:265–276. doi: 10.1007/s12672-010-0050-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Tsuji M, Tamai Y, Wada K, Nakamura K, Hayashi M, Takeda N, et al. Associations of intakes of fat, dietary fiber, soy isoflavones, and alcohol with levels of sex hormones and prolactin in premenopausal Japanese women. Cancer Causes Control. 2012;23:683–689. doi: 10.1007/s10552-012-9935-8. [DOI] [PubMed] [Google Scholar]
- 12.Dorgan JF, Reichman ME, Judd JT, Brown C, Longcope C, Schatzkin A, et al. Relation of energy, fat, and fiber intakes to plasma concentrations of estrogens and androgens in premenopausal women. Am J Clin Nutr. 1996;64:25–31. doi: 10.1093/ajcn/64.1.25. [DOI] [PubMed] [Google Scholar]
- 13.Rose DP, Lubin M, Connolly JM. Effects of diet supplementation with wheat bran on serum estrogen levels in the follicular and luteal phases of the menstrual cycle. Nutrition. 1997;13:535–539. doi: 10.1016/s0899-9007(97)00032-4. [DOI] [PubMed] [Google Scholar]
- 14.Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K. Relations of insulin resistance and serum concentrations of estradiol and sex hormone-binding globulin to potential breast cancer risk factors. Jpn J Cancer Res. 2000;91:948–953. doi: 10.1111/j.1349-7006.2000.tb01039.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Dorgan JF, Judd JT, Longcope C, Brown C, Schatzkin A, Clevidence BA, et al. Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study. Am J Clin Nutr. 1996;64:850–855. doi: 10.1093/ajcn/64.6.850. [DOI] [PubMed] [Google Scholar]
- 16.RH L. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004;134:3479S–3485S. doi: 10.1093/jn/134.12.3479S. [DOI] [PubMed] [Google Scholar]
- 17.Canene-Adams KLB, Wang S, Jeffery EH, Clinton SK, Erdman JW., Jr Combinations of tomato and broccoli enhance antitumor activity in dunning r-3327-h prostate adenocarcinomas. Cancer Res. 2007;67:836–843. doi: 10.1158/0008-5472.CAN-06-3462. [DOI] [PubMed] [Google Scholar]
- 18.McCullough ML, Feskanich D, Stampfer MJ, Giovannucci EL, Rimm EB, Hu FB, et al. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr. 2002;76:1261–1271. doi: 10.1093/ajcn/76.6.1261. [DOI] [PubMed] [Google Scholar]
- 19.Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med. 2008;168:713–720. doi: 10.1001/archinte.168.7.713. [DOI] [PubMed] [Google Scholar]
- 20.Fung TTRK, Mantzoros CS, Manson JE, Willett WC, Hu FB. Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation. 2009;119:1093–1100. doi: 10.1161/CIRCULATIONAHA.108.816736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies. Int J Cancer. 2014;135:1884–1897. doi: 10.1002/ijc.28824. [DOI] [PubMed] [Google Scholar]
- 22.Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M, et al. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012;142:1009–1018. doi: 10.3945/jn.111.157222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Schwingshackl L, Hoffmann G. Diet quality as assessed by the healthy eating index, the alternate healthy eating index, the dietary approaches to stop hypertension score, and health outcomes: a systematic review and meta-analysis of cohort studies. J Acad Nutr Diet. 2015;115:780–800. e5. doi: 10.1016/j.jand.2014.12.009. [DOI] [PubMed] [Google Scholar]
- 24.Bosire C, Stampfer MJ, Subar AF, Park Y, Kirkpatrick SI, Chiuve SE, et al. Index-based dietary patterns and the risk of prostate cancer in the NIH-AARP diet and health study. Am J Epidemiol. 2013;177:504–513. doi: 10.1093/aje/kws261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Belin RJ, Greenland P, Allison M, Martin L, Shikany JM, Larson J, et al. Diet quality and the risk of cardiovascular disease: the Women's Health Initiative (WHI) Am J Clin Nutr. 2011;94:49–57. doi: 10.3945/ajcn.110.011221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Boggs DA, Ban Y, Palmer JR, Rosenberg L. Higher diet quality is inversely associated with mortality in African-American women. J Nutr. 2015;145:547–554. doi: 10.3945/jn.114.195735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Harmon BE, Boushey CJ, Shvetsov YB, Ettienne R, Reedy J, Wilkens LR, et al. Associations of key diet-quality indexes with mortality in the Multiethnic Cohort: the Dietary Patterns Methods Project. Am J Clin Nutr. 2015;101:587–597. doi: 10.3945/ajcn.114.090688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Fung TT, Hu FB, McCullough ML, Newby PK, Willett WC, Holmes MD. Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women. J Nutr. 2006;136:466–472. doi: 10.1093/jn/136.2.466. [DOI] [PubMed] [Google Scholar]
- 29.Fung TT, Hu FB, Hankinson SE, Willett WC, Holmes MD. Low-carbohydrate diets, dietary approaches to stop hypertension-style diets, and the risk of postmenopausal breast cancer. Am J Epidemiol. 2011;174:652–660. doi: 10.1093/aje/kwr148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Fung TT, Hu FB, Barbieri RL, Willett WC, Hankinson SE. Dietary patterns, the Alternate Healthy Eating Index and plasma sex hormone concentrations in postmenopausal women. Int J Cancer. 2007;121:803–809. doi: 10.1002/ijc.22728. [DOI] [PubMed] [Google Scholar]
- 31.Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995;87:1297–1302. doi: 10.1093/jnci/87.17.1297. [DOI] [PubMed] [Google Scholar]
- 32.Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev. 2006;15:972–978. doi: 10.1158/1055-9965.EPI-05-0848. [DOI] [PubMed] [Google Scholar]
- 33.Tworoger SS, Lee IM, Buring JE, Hankinson SE. Plasma androgen concentrations and risk of incident ovarian cancer. Am J Epidemiol. 2008;167:211–218. doi: 10.1093/aje/kwm278. [DOI] [PubMed] [Google Scholar]
- 34.Karlson EW, Chibnik LB, McGrath M, Chang SC, Keenan BT, Costenbader KH, et al. A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis. Arthritis Res Ther. 2009;11:R97. doi: 10.1186/ar2742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst. 2004;96:1856–1865. doi: 10.1093/jnci/djh336. [DOI] [PubMed] [Google Scholar]
- 36.Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1998;90:1292–1299. doi: 10.1093/jnci/90.17.1292. [DOI] [PubMed] [Google Scholar]
- 37.Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51–65. doi: 10.1093/oxfordjournals.aje.a114086. [DOI] [PubMed] [Google Scholar]
- 38.Willett WC, Reynolds RD, Cottrell-Hoehner S, Sampson L, Browne ML. Validation of a semi-quantitative food frequency questionnaire: comparison with a 1-year diet record. J Am Diet Assoc. 1987;87:43–47. [PubMed] [Google Scholar]
- 39.Fung TT, McCullough ML, Newby PK, Manson JE, Meigs JB, Rifai N, et al. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2005;82:163–173. doi: 10.1093/ajcn.82.1.163. [DOI] [PubMed] [Google Scholar]
- 40.Sacks FM. Dietary approaches to stop hypertension. Ann Epidemiol. 1995;5:502. doi: 10.1016/1047-2797(95)00103-4. [DOI] [PubMed] [Google Scholar]
- 41.Fujimoto VY, Clifton DK, Cohen NL, Soules MR. Variability of serum prolactin and progesterone levels in normal women: the relevance of single hormone measurements in the clinical setting. Obstet Gynecol. 1990;76:71–78. [PubMed] [Google Scholar]
- 42.Rosner B. Percentage points for a generalized ESD many-outlier procedure. Technometrics. 1983;25:165–172. [Google Scholar]
- 43.Rosner B, Cook N, Portman R, Daniels S, Falkner B. Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol. 2008;167:653–666. doi: 10.1093/aje/kwm348. [DOI] [PubMed] [Google Scholar]
- 44.Rice MS, Tworoger SS, Rosner BA, Pollak MN, Hankinson SE, Tamimi RM. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies. Breast Cancer Res Treat. 2012;136:805–812. doi: 10.1007/s10549-012-2303-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Harrell FE, Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80:1198–1202. doi: 10.1093/jnci/80.15.1198. [DOI] [PubMed] [Google Scholar]
- 46.Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551–561. doi: 10.1002/sim.4780080504. [DOI] [PubMed] [Google Scholar]
- 47.Govindarajulu USME, Ganquli B, Spiegelman D, Eisen EA. The comparison of alternative smoothing methods for fitting non-linear exposure-response relationships with Cox models in a simulation study. Int J Biostat. 2009;5 doi: 10.2202/1557-4679.1104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Ingram DM, Bennett FC, Willcox D, de Klerk N. Effect of low-fat diet on female sex hormone levels. J Natl Cancer Inst. 1987;79:1225–1229. [PubMed] [Google Scholar]
- 49.Schliep KC, Schisterman EF, Mumford SL, Pollack AZ, Perkins NJ, Ye A, et al. Energy-containing beverages: reproductive hormones and ovarian function in the BioCycle Study. Am J Clin Nutr. 2013;97:621–630. doi: 10.3945/ajcn.111.024752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Nagata C, Kabuto M, Shimizu H. Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr Cancer. 1998;30:21–24. doi: 10.1080/01635589809514635. [DOI] [PubMed] [Google Scholar]
- 51.Lucero J, Harlow BL, Barbieri RL, Sluss P, Cramer DW. Early follicular phase hormone levels in relation to patterns of alcohol, tobacco, and coffee use. Fertil Steril. 2001;76:723–729. doi: 10.1016/s0015-0282(01)02005-2. [DOI] [PubMed] [Google Scholar]
- 52.Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Caffeinated and alcoholic beverage intake in relation to ovulatory disorder infertility. Epidemiology. 2009;20:374–381. doi: 10.1097/EDE.0b013e31819d68cc. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Cohen LA. Dietary fiber and breast cancer. Anticancer Res. 1999;19:3685–3688. [PubMed] [Google Scholar]
- 54.Fowke JH, Longcope C, Hebert JR. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000;9:773–779. [PubMed] [Google Scholar]
- 55.Arts CJ, Govers CA, van den Berg H, Wolters MG, van Leeuwen P, Thijssen JH. In vitro binding of estrogens by dietary fiber and the in vivo apparent digestibility tested in pigs. J Steroid Biochem Mol Biol. 1991;38:621–628. doi: 10.1016/0960-0760(91)90321-u. [DOI] [PubMed] [Google Scholar]
- 56.Shultz TD, Howie BJ. In vitro binding of steroid hormones by natural and purified fibers. Nutr Cancer. 1986;8:141–147. doi: 10.1080/01635588609513887. [DOI] [PubMed] [Google Scholar]
- 57.Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dwyer JT, Swenson L, et al. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med. 1982;307:1542–1547. doi: 10.1056/NEJM198212163072502. [DOI] [PubMed] [Google Scholar]
- 58.Goldin BR, Adlercreutz H, Gorbach SL, Woods MN, Dwyer JT, Conlon T, et al. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr. 1986;44:945–953. doi: 10.1093/ajcn/44.6.945. [DOI] [PubMed] [Google Scholar]
- 59.Kendall ME, Cohen LA. Effect of dietary fiber on mammary tumorigenesis, estrogen metabolism, and lipid excretion in female rats. In Vivo. 1992;6:239–245. [PubMed] [Google Scholar]
- 60.Wynder EL, Cohen LA, Muscat JE, Winters B, Dwyer JT, Blackburn G. Breast cancer: weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst. 1997;89:766–775. doi: 10.1093/jnci/89.11.766. [DOI] [PubMed] [Google Scholar]
- 61.Bruning PF, Bonfrer JM. Free fatty acid concentrations correlated with the available fraction of estradiol in human plasma. Cancer Res. 1986;46:2606–2609. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.